Bone marrow endothelial cells secrete thymosin beta4 and AcSDKP

Area of Science:

• Hematology
• Cell Biology
• Biochemistry

Background:

• Bone marrow endothelial cells (BMECs) are crucial for the hematopoietic stem cell niche.
• BMECs produce cytokines that influence hematopoietic stem cell (HSC) expansion and differentiation.
• Previous research suggests BMEC-derived inhibitors protect HSCs from excessive differentiation.

Purpose of the Study:

• To investigate if murine bone marrow endothelial cells (mBMECs) produce thymosin beta4 (Tbeta4) and AcSDKP.
• To determine the effect of mBMEC-conditioned medium (mBMEC-CM) and these specific inhibitors on hematopoietic progenitor proliferation.

Main Methods:

• mBMECs were cultured in serum-free medium.
• Gene expression analyzed via RT-PCR for thymosin-beta.
• Tbeta4 and AcSDKP concentrations measured using HPLC and mass spectrometry.
• Colony-forming unit granulocyte-macrophage (CFU-GM) assays assessed proliferation effects.

Main Results:

• mBMECs expressed Tbeta4 mRNA and secreted both Tbeta4 and AcSDKP.
• Tbeta4 was found in the 3-10 kD fraction, and AcSDKP in the <3 kD fraction of mBMEC-CM.
• mBMEC-CM (<3 kD), Tbeta4, and AcSDKP significantly inhibited CFU-GM growth in a dose-dependent manner.
• Angiotensin-converting enzyme (ACE) partially reversed the inhibitory effect of mBMEC-CM (<3 kD).

Conclusions:

• Murine bone marrow endothelial cells express and secrete Tbeta4 and AcSDKP.
• Both secreted factors inhibit hematopoietic progenitor proliferation, contributing to the regulation of hematopoiesis.
• Tbeta4 and AcSDKP are key molecular components mediating the inhibitory effects of BMECs on HSCs.